BiotechTube
Home/X4 Pharmaceuticals/Gary J. Bridger, PhD
GJ

Gary J. Bridger, PhD

Board Member

X4 Pharmaceuticals

Therapeutic Areas

Rare Immune DisordersHematology

X4 Pharmaceuticals Pipeline

DrugIndicationPhase
XOLREMDI (mavorixafor)WHIM SyndromeApproved
MavorixaforChronic Neutropenic DisordersPhase 3

Leadership Team at X4 Pharmaceuticals

AC
Adam Craig, MD, PhD, MBA
Executive Chair
JV
John Volpone
President, Chief Operating Officer
DK
David Kirske
Chief Financial Officer
View full X4 Pharmaceuticals profile